Management maintained a confident tone, particularly about LEQEMBI and pipeline progress, with Viehbacher repeatedly emphasizing the long-term growth prospects of Biogen’s diversified portfolio.

Consider the benefit of LEQEMBI for the treatment of AD and the potential risk of serious ARIA events when deciding to initiate treatment with LEQEMBI.

A big win for the company, but many are focusing on the commercialization of Leqembi, the drug Biogen is counting on to help overcome setbacks from its older Alzheimer's treatment Aduhelm.

The FDA has granted accelerated approval to Leqembi (lecanemab-irmb) for the treatment of Alzheimer disease.

Leqembi's EU-wide marketing authorization was refused because the drug's effect on delaying cognitive decline does not counterbalance the risk for serious adverse events.

STOCKHOLM, May 15, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that Leqembi sales are expected to total JPY 76.5 billion (approximately SEK ...

Those losing their loved ones to Alzheimer’s should temper their expectations of new drug Leqembi, which was approved by the FDA last week.

The FDA has granted full approval to the first therapy for Alzheimer’s disease clearly shown to slow the cognitive decline associated with the disease — a milestone in treatment, even if the ...

European regulators have recommended granting marketing authorisation for the Alzheimer's drug lecanemab after an initial negative opinion earlier this year. Lecanemab, marketed as Leqembi, is ...

With the launch of intravenous Leqembi (lecanemab-irmb) for Alzheimer’s disease (AD) underway, Priya Singhal, Biogen Inc.’s head of development and interim head of research, said the firm, along with ...

Biogen's Leqembi offers hope for Alzheimer's patients by slowing cognitive decline. Patients like Missie Meeks highlight the benefits, but challenges with side effects, insurance, and diagnostics ...

Biogen Inc Chief Executive Officer Christopher Viehbacher said on Wednesday he is banking on high-profile launches of Alzheimer's disease treatment Leqembi and depression drug zuranolone, as well ...